NPR Examines Whether Goal Of Treating All HIV-Positive People With ARVs Is Feasible

Noting new guidelines released at the XIX International AIDS Conference (AIDS 2012) in Washington, D.C., this week “call for everybody with HIV to be started on antiretroviral drugs [ARVs] as soon as they test positive for the virus,” NPR’s “Shots” blog examines “whether the goal is achievable, and who would pay for this enormous expansion in treatment.” “Right now about eight million people across the world are getting treated for HIV at a cost of around $17 billion a year,” the blog writes, adding, “Universal treatment would cost another $22 billion, by some estimates.” The blog notes Bernhard Schwartlander, director for evidence, strategy and results at UNAIDS, in a plenary speech at the conference on Tuesday “offered up several possible ways to raise the money,” including a tax on shipping and aviation fuel (Knox, 7/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.